Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AMINOBUTANOIC ACID DERIVATIVE
Document Type and Number:
Japanese Patent JP2003212831
Kind Code:
A
Abstract:

To provide a compound of formula (1) inhibiting matrix proteinase and useful for preventing and/or treating rheumatoid arthritis, osteoarthritis, pathological bone resorption, osteoporosis, periodontal disease, institutional nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, corneal abscess, diseases caused by the metastatic infiltration or propagation of cancer cells, autoimmune diseases (Crohn disease, Sjoegren disease, etc.), diseases caused by the wandering of leukocyte-based cells in blood vessels or their infiltration, angiogensis, multiple sclerosis, aotic aneurysm, endometriosis, etc.

This aminobutanoic acid derivative expressed by formula (1) and its salt are provided.


Inventors:
TAKAHASHI KANJI
SUGIURA TSUNEYUKI
Application Number:
JP2002344969A
Publication Date:
July 30, 2003
Filing Date:
October 07, 1998
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ONO PHARMACEUTICAL CO
International Classes:
A61K31/16; A61K31/18; A61K31/192; A61K31/197; A61K31/22; A61K31/222; A61K31/341; A61K31/343; A61K31/351; A61K31/381; A61K31/385; A61K31/40; A61K31/4015; A61K31/402; A61K31/404; A61K31/4045; A61K31/405; A61K31/415; A61K31/4164; A61K31/4166; A61K31/4192; A61K31/423; A61K31/428; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/445; A61K31/4465; A61K31/47; A61K31/5377; A61K31/69; A61K31/695; A61P1/02; A61P1/04; A61P1/16; A61P7/00; A61P9/00; A61P9/10; A61P11/00; A61P13/12; A61P15/00; A61P19/02; A61P19/08; A61P19/10; A61P25/00; A61P27/02; A61P29/00; A61P35/00; A61P35/04; A61P37/06; A61P43/00; C07C233/63; C07C233/83; C07C235/06; C07C235/16; C07C235/42; C07C235/52; C07C237/42; C07C255/57; C07C259/06; C07C259/08; C07C323/42; C07C323/60; C07C327/30; C07D207/325; C07D207/408; C07D207/416; C07D209/14; C07D209/18; C07D209/42; C07D211/14; C07D211/46; C07D211/62; C07D211/70; C07D213/56; C07D213/68; C07D213/70; C07D213/81; C07D215/14; C07D231/12; C07D233/61; C07D233/74; C07D263/56; C07D277/62; C07D307/68; C07D307/79; C07D307/81; C07D307/85; C07D309/12; C07D333/16; C07D333/38; C07D333/60; C07D339/08; C07D405/12; C07F5/02; C07F7/18; C07D249/18; (IPC1-7): C07C233/63; A61K31/16; A61K31/18; A61K31/192; A61K31/197; A61K31/22; A61K31/222; A61K31/341; A61K31/343; A61K31/351; A61K31/381; A61K31/385; A61K31/40; A61K31/4015; A61K31/402; A61K31/404; A61K31/4045; A61K31/405; A61K31/415; A61K31/4164; A61K31/4166; A61K31/4192; A61K31/423; A61K31/428; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/445; A61K31/4465; A61K31/47; A61K31/5377; A61K31/69; A61K31/695; A61P1/02; A61P1/04; A61P1/16; A61P7/00; A61P9/00; A61P9/10; A61P11/00; A61P13/12; A61P15/00; A61P19/02; A61P19/08; A61P19/10; A61P25/00; A61P27/02; A61P29/00; A61P35/00; A61P35/04; A61P37/06; A61P43/00; C07C233/83; C07C235/06; C07C235/16; C07C235/42; C07C235/52; C07C237/42; C07C255/57; C07C259/06; C07C259/08; C07C323/42; C07C323/60; C07C327/30; C07D207/325; C07D207/408; C07D207/416; C07D209/14; C07D209/18; C07D209/42; C07D211/14; C07D211/46; C07D211/62; C07D211/70; C07D213/56; C07D213/68; C07D213/70; C07D213/81; C07D215/14; C07D231/12; C07D233/61; C07D233/74; C07D249/18; C07D263/56; C07D277/62; C07D307/68; C07D307/79; C07D307/81; C07D307/85; C07D309/12; C07D333/16; C07D333/38; C07D333/60; C07D339/08; C07D405/12; C07F5/02; C07F7/18
Attorney, Agent or Firm:
Kunihisa Oya (2 outside)